Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.
Zhou C, Tang KJ, Cho BC, Liu B, Paz-Ares L, Cheng S, Kitazono S, Thiagarajan M, Goldman JW, Sabari JK, Sanborn RE, Mansfield AS, Hung JY, Boyer M, Popat S, Mourão Dias J, Felip E, Majem M, Gumus M, Kim SW, Ono A, Xie J, Bhattacharya A, Agrawal T, Shreeve SM, Knoblauch RE, Park K, Girard N; PAPILLON Investigators. Zhou C, et al. Among authors: thiagarajan m. N Engl J Med. 2023 Nov 30;389(22):2039-2051. doi: 10.1056/NEJMoa2306441. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870976 Clinical Trial.
Outcomes of Patients with EGFR-Mutant Advanced NSCLC in a Developing Country in Southeast Asia.
How SH, Liam CK, Zainal Abidin MA, Hasbullah HH, Tho LM, Ho GF, Muhamad Nor I, Pang YK, Ho KF, Thiagarajan M, Ariffin R, Samsudin A, Omar A, Tan SN, Ong CK, Soon SY, Poh ME. How SH, et al. Among authors: thiagarajan m. Cancer Manag Res. 2022 Jun 16;14:1995-2005. doi: 10.2147/CMAR.S364713. eCollection 2022. Cancer Manag Res. 2022. PMID: 35733510 Free PMC article.
Does dose reduction of afatinib affect treatment outcomes of patients with EGFR-mutant metastatic non-small cell lung cancer in real-world clinical practice?
Poh ME, Chai CS, Liam CK, Ho GF, Pang YK, Hasbullah HH, Tho LM, Muhamad Nor I, Ho KF, Thiagarajan M, Samsudin A, Omar A, Ong CK, Soon SY, Tan SN, How SH. Poh ME, et al. Among authors: thiagarajan m. Transl Lung Cancer Res. 2024 Feb 29;13(2):307-320. doi: 10.21037/tlcr-23-691. Epub 2024 Feb 28. Transl Lung Cancer Res. 2024. PMID: 38496703 Free PMC article.
Malaysian Consensus Statement for the Diagnosis and Management of Acromegaly.
Hussein Z, Bidin ML, Alias A, Thiagarajan M, Latif KA, Ratnasingam J, Seman WJW, Nasruddin A. Hussein Z, et al. Among authors: thiagarajan m. J ASEAN Fed Endocr Soc. 2019;34(1):8-14. doi: 10.15605/jafes.034.01.03. Epub 2019 May 28. J ASEAN Fed Endocr Soc. 2019. PMID: 33442131 Free PMC article.
Diagnostic work-up and systemic treatment for advanced non-squamous non-small-cell lung cancer in four Southeast Asian countries.
Soo R, Mery L, Bardot A, Kanesvaran R, Keong TC, Pongnikorn D, Prasongsook N, Hutajulu SH, Irawan C, Manan AA, Thiagarajan M, Sripan P, Peters S, Storm H, Bray F, Stahel R. Soo R, et al. Among authors: thiagarajan m. ESMO Open. 2022 Oct;7(5):100560. doi: 10.1016/j.esmoop.2022.100560. Epub 2022 Aug 18. ESMO Open. 2022. PMID: 35988454 Free PMC article.
Real-World Treatment and Outcomes of ALK-Positive Metastatic Non-Small Cell Lung Cancer in a Southeast Asian Country.
Poh ME, How SH, Ho GF, Pang YK, Hasbullah HH, Tho LM, Muhamad Nor I, Lim BC, Ho KF, Thiagarajan M, Samsudin A, Omar A, Ong CK, Soon SY, Tan JYK, Zainal Abidin MA. Poh ME, et al. Among authors: thiagarajan m. Cancer Manag Res. 2023 Jan 13;15:31-41. doi: 10.2147/CMAR.S393729. eCollection 2023. Cancer Manag Res. 2023. PMID: 36660237 Free PMC article.
Association between pre-existing cardiometabolic comorbidities and the pathological profiles of breast cancer at initial diagnosis: a cross sectional study.
Subramaniam S, Kong YC, Yip CH, Thiagarajan M, Pailoor J, Zaharah H, Taib NA, See MH, Sarfati D, Bhoo-Pathy N. Subramaniam S, et al. Among authors: thiagarajan m. Ecancermedicalscience. 2023 Feb 23;17:1512. doi: 10.3332/ecancer.2022.1512. eCollection 2023. Ecancermedicalscience. 2023. PMID: 37113731 Free PMC article.
Programmed death-ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non-small-cell lung cancer in a resource-limited country.
How SH, Tho LM, Liam CK, Hasbullah HH, Ho GF, Muhammad Nor I, Poh ME, Ho KF, Thiagarajan M, Samsudin A, Omar A, Ong CK, Pang YK, Soon SY. How SH, et al. Among authors: thiagarajan m. Thorac Cancer. 2022 Jun;13(11):1676-1683. doi: 10.1111/1759-7714.14442. Epub 2022 May 3. Thorac Cancer. 2022. PMID: 35502623 Free PMC article.
82 results